Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For LGEN.L
Valuation Weak
28%
Profitability n.A.
Fin. Growth n.A.
Leverage & Liquidity Weak
17%
Per Share Metrics Best
100%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q2 Q4 Δ in %
Current Ratio -99.96 0.11 290.74
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -100.00 -76.20 0.00
Naive Interpretation member
2 Per Share
Metric Q2 Q4 Δ in %
Book Value 100.00 0.82 0.00
Cash 100.00 1.06 0.00
Capex -100.00 -0.01 0.00
Free Cash Flow 100.00 1.00 0.00
Revenue 100.00 5.22 0.00
Naive Interpretation member
3 Profitability
Metric Q2 Q4 Δ in %
Gross Margin 100.00 1.00 0.00
Operating Margin 100.00 0.03 0.00
ROA n.A. < 0.005 n.A.
ROE n.A. 0.03 n.A.
ROIC n.A. -0.01 n.A.
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of LGEN.L is permitted for members.
5 Growth
The "Growth Entry" for the Focus of LGEN.L is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of LGEN.L is permitted for members.